A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer
Shom Goel(The University of Melbourne), Sara M. Tolaney(Dana-Farber Cancer Institute)
Cited by 7
Related Papers
Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study
|npj Breast Cancer|2022|81
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies
|Clinical Cancer Research|2024|11